Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota.

Li H, Ban C, An J, Yang J, Ren J, Wu Y, Shen Z, Zhang J, Gu X, Liu H

Open source

DOI
10.1248/bpb.b26-00124
Published
2026
Container
Biological & pharmaceutical bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1248/bpb.b26-00124,
  title = {Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota.},
  author = {Li H and Ban C and An J and Yang J and Ren J and Wu Y and Shen Z and Zhang J and Gu X and Liu H},
  year = {2026},
  journal = {Biological \& pharmaceutical bulletin},
  doi = {10.1248/bpb.b26-00124},
  url = {https://doi.org/10.1248/bpb.b26-00124}
}

RIS

TY  - JOUR
TI  - Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota.
AU  - Li H
AU  - Ban C
AU  - An J
AU  - Yang J
AU  - Ren J
AU  - Wu Y
AU  - Shen Z
AU  - Zhang J
AU  - Gu X
AU  - Liu H
PY  - 2026
JO  - Biological & pharmaceutical bulletin
DO  - 10.1248/bpb.b26-00124
UR  - https://doi.org/10.1248/bpb.b26-00124
ER  - 

APA

H, L., C, B., J, A., J, Y., J, R., Y, W., Z, S., J, Z., X, G., & H, L. (2026). Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota.. Biological & pharmaceutical bulletin. https://doi.org/10.1248/bpb.b26-00124

Source records